HLA-Associated Clinical Progression Correlates with Epitope Reversion Rates in Early Human Immunodeficiency Virus Infection
暂无分享,去创建一个
M. Carrington | A. McLean | R. Phillips | H. Fryer | J. Weber | M. Mcclure | N. Robinson | S. Fidler | A. Duda | A. J. Frater | S. Dustan | S. Kaye | J. Fox | L. Lee-Turner
[1] David Heckerman,et al. Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection , 2008, Journal of Virology.
[2] D. Heckerman,et al. Central Role of Reverting Mutations in HLA Associations with Human Immunodeficiency Virus Set Point , 2008, Journal of Virology.
[3] Hui Li,et al. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection , 2008, Proceedings of the National Academy of Sciences.
[4] Tanmoy Bhattacharya,et al. HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load , 2008, Journal of Virology.
[5] R. Weiss. Special Anniversary Review: Twenty-five years of human immunodeficiency virus research: successes and challenges , 2008, Clinical and experimental immunology.
[6] David A. Price,et al. Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover , 2007, The Journal of experimental medicine.
[7] David Heckerman,et al. Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 , 2007, PLoS pathogens.
[8] N. Pantazis,et al. Slower CD4 cell decline following cessation of a 3 month course of HAART in primary HIV infection: findings from an observational cohort , 2007, AIDS.
[9] Becca Asquith,et al. In vivo CD8+ T cell control of immunodeficiency virus infection in humans and macaques , 2007, Proceedings of the National Academy of Sciences.
[10] B. Walker,et al. Effective T-Cell Responses Select Human Immunodeficiency Virus Mutants and Slow Disease Progression , 2007, Journal of Virology.
[11] D. Heckerman,et al. Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations , 2007, Science.
[12] Bin Li,et al. Rapid Reversion of Sequence Polymorphisms Dominates Early Human Immunodeficiency Virus Type 1 Evolution , 2006, Journal of Virology.
[13] Todd M. Allen,et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8+ T Cell Response against HIV-1 , 2006, PLoS medicine.
[14] E. Holmes,et al. Passive Sexual Transmission of Human Immunodeficiency Virus Type 1 Variants and Adaptation in New Hosts , 2006, Journal of Virology.
[15] Mario Roederer,et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells. , 2006, Blood.
[16] D. Cornforth,et al. HIV-1 Epitope-Specific CD8+ T Cell Responses Strongly Associated with Delayed Disease Progression Cross-Recognize Epitope Variants Efficiently1 , 2006, The Journal of Immunology.
[17] B. Walker,et al. Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.
[18] Becca Asquith,et al. Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.
[19] J. Goedert,et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis , 2005, Nature Medicine.
[20] Andrew K. Sewell,et al. Transmission and accumulation of CTL escape variants drive negative associations between HIV polymorphisms and HLA , 2005, The Journal of experimental medicine.
[21] Bette Korber,et al. Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA , 2004, Nature.
[22] Bernard Hirschel,et al. Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[23] B. Walker,et al. Immune Escape Precedes Breakthrough Human Immunodeficiency Virus Type 1 Viremia and Broadening of the Cytotoxic T-Lymphocyte Response in an HLA-B27-Positive Long-Term-Nonprogressing Child , 2004, Journal of Virology.
[24] G. M. Ortiz,et al. Relevance of HIV-1-Specific CD4+ Helper T-Cell Responses During Structured Treatment Interruptions in Patients With CD4+ T-Cell Nadir Above 400/mm3 , 2004, Journal of acquired immune deficiency syndromes.
[25] E. Rosenberg,et al. Progressive reversion of human immunodeficiency virus type 1 resistance mutations in vivo after transmission of a multiply drug-resistant virus. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[26] D. Strick,et al. Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.
[27] A. Oxenius,et al. Virological and immunological effects of short-course antiretroviral therapy in primary HIV infection , 2002, AIDS.
[28] H. Günthard,et al. Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[29] P. Klenerman,et al. HIV: current opinion in escapology. , 2002, Current opinion in microbiology.
[30] C. Moore,et al. Evidence of HIV-1 Adaptation to HLA-Restricted Immune Responses at a Population Level , 2002, Science.
[31] M. Carrington,et al. HLA and AIDS: a cautionary tale. , 2001, Trends in molecular medicine.
[32] J J Goedert,et al. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. , 2001, The New England journal of medicine.
[33] Edward C. Holmes,et al. Clustered Mutations in HIV-1 Gag Are Consistently Required for Escape from Hla-B27–Restricted Cytotoxic T Lymphocyte Responses , 2001, The Journal of experimental medicine.
[34] S. Osmanov,et al. Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines. , 2000, AIDS research and human retroviruses.
[35] S. Rowland-Jones,et al. Direct visualization of HIV-1-specific cytotoxic T lymphocytes during primary infection , 2000, AIDS.
[36] B. Walker,et al. Lack of Viral Escape and Defective In Vivo Activation of Human Immunodeficiency Virus Type 1-Specific Cytotoxic T Lymphocytes in Rapidly Progressive Infection , 1999, Journal of Virology.
[37] J. Goedert,et al. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.
[38] S. Oka,et al. Identification of multiple HIV-1 CTL epitopes presented by HLA-B*5101 molecules. , 1999, Human immunology.
[39] D. Montefiori,et al. Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes. , 1999, Science.
[40] S. Oka,et al. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS. , 1997, Journal of immunology.
[41] Martin A. Nowak,et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS , 1997, Nature Medicine.
[42] G. Shaw,et al. Virus-specific CD8+ cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection , 1994, Journal of virology.
[43] D. Ho,et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.
[44] John W. Ward,et al. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. , 1993, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.
[45] David Heckerman,et al. CD8+ T-cell responses to different HIV proteins have discordant associations with viral load , 2007, Nature Medicine.
[46] E. Domingo,et al. Cytotoxic T-lymphocyte responses to HIV-1 reverse transcriptase (review). , 1998, Viral immunology.
[47] Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. , 1987, MMWR supplements.